Problems viewing this newsletter? View it in your browser >

February 29, 2012

Dear Advocate,

This update describes a range of opportunities for advocates to engage with the upcoming Conference on Retroviruses and Opportunistic Infections (March 5-8). This includes post-conference webinars on oral PrEP and rectal microbicides to be held on March 13th and 15th, respectively.

Are you interested in tracking sessions of relevance to biomedical HIV prevention research? Check out the session list below.

Are you attending the conference and seeking to meet up, analyze and strategize with other advocates? Join us for lunchtime check-ins—check the conference message board for location information and/or email us.

Would you like to delve deeper into key data? Join upcoming webinars on oral tenofovir-based PrEP on Tuesday, March 13 and an IRMA-AVAC call on rectal microbicides on Thursday, March 15. Both webinars will be held at 10 AM ET and call-in numbers and registration details will be available at next week.

The 19th Conference on Retroviruses and Opportunistic Infections (CROI) is taking place next week in Seattle. CROI is billed as an annual "meeting of the minds" between laboratory and clinical science. This year's meeting will bring updates on PrEP, microbicides, vaccines, voluntary medical male circumcision, treatment as prevention and other elements of combination prevention. Many of the conference sessions are recorded—and session webcasts will be available on the conference website starting next week.

HIV prevention research-related sessions at CROI 

Sessions of interest include (times listed are local Seattle time):

  • Martin Delaney Lecture, Community Responses to PrEP and Treatment as Prevention, Nikos Dedes; Monday, 12:50-1:20pm
  • N’Galy-Mann Lecture, CAPRISA: Partnering for Scientific Innovation in HIV Prevention and Treatment, Salim Abdool Karim and Quarraisha Abdool Karim; Monday opening session, 5-7pm
  • Clinical Trials Design Workshop; Monday workshop, 2:30-4:30pm
  • 17th Bernard Fields Lecture, Defying the Structure and Variability of HIV with Broadly Neutralizing Antibodies, Dennis Burton; Monday opening session, 5-7pm
  • ART for Prevention: The Science and the Art, Wafaa El-Sadr; Tuesday plenary, 8:30-9am
  • Critical Treatment Issues in Women and Children; Tuesday oral abstract session, 10am-12:15pm (includes abstracts on hormonal contraceptives use and HIV risk)
  • HIV Prevention: PrEP, Microbicides, and Circumcision; Tuesday oral abstract session, 10am-12:15pm (includes data from FEM-PrEP, iPrEx and Partners PrEP trials; MTN 007, a Phase I rectal microbicide study of reformulated TFV gel; and voluntary medical male circumcision)
  • Next Steps in Using ARV for Prevention; Tuesday symposium, 4-6pm
  • Elimination of MTCT of HIV, Dorothy Mbori-Ngacha; Wednesday plenary, 8:30-9am
  • Structure and Function of the HIV-1 Env, Joseph Sodroski; Wednesday plenary, 9-9:30am
  • Advances in Vaccines and Immune-based Therapies; Wednesday oral abstract session, 10am-12:15pm
  • Novel Approaches to Testing and Linkage to Care; Wednesday themed discussion,1-2pm
  • Correlates of Risk in RV144 and Related Trials; Wednesday themed discussion, 1-2pm
  • Animal and Human Studies of PrEP and Vaginal Rings; Wednesday themed discussion, 1-2pm
  • New Frontiers in HIV Testing; Wednesday symposium, 4-6pm
  • Pathways toward a Cure: Viral Latency and Reservoirs; Wednesday symposium, 4-6pm
  • AIDS and the Global Burden of Disease, Christopher Murray; Thursday plenary,9-9:30am
  • Ontogeny of a Protective Immune Response to HIV; Thursday symposium, 4-6pm

If you are planning or know of a relevant event at CROI, please email us. We'll add it to the list above, which is also available online at There you'll find the latest from CROI, information on advocates’ events on-site and updates on the post-CROI webinar series. For those of you who won't be attending in person, you can follow the conference proceedings online via regular reports from NAM/AIDSMAP.

Hope to see many of you in Seattle!


Forward This IssueDo you know someone who might be interested in receiving this newsletter?
Forward > 

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
Unsubscribe > 

Contact Us T: +1 212 796 6423